Literature DB >> 11173621

Low Serum Pancreatitis-Associated Protein Does not Exclude Complications in Mild Acute Pancreatitis.

Janja Polanec1, Zlatko P Pavelic, Joe Osredkar.   

Abstract

Normal serum PAP levels on admission to the hospital in patiens with acute pancreatitis has been proposed to help select the patients who are not going to develop complications. The aims of this study were, first, to assess the specificity of serum pancreatitis associated protein (PAP) serology test and second, to evalute the usefulness of the test for prediciting complications in acute pancreatitis on admission to the hospital. The sensitivity of the PAP ELISA in patiens with acute pancreatitis on admission to the hospital was 70% and the serum PAP levels significantly higher than in healthy controls (p < 0.0001). However, the serum PAP levels in patients with acute pancreatitis were not significantly different from values in patients with various abdominal diseases (p < 0.58). Serum PAP levels gave good correlation to APACHE II (p = 0.02) and CRP (p = 0.01). Two patients with local complications (necrotizing pancreatitis, pancreatic fluid collection) had elevated serum PAP levels on admission to the hospital (> 100 ng/ml). The diagnostic specififity of PAP ELISA is low. Patients, who develop local complications in acute pancreatitis can not be excluded by normal serum PAP levels on admission to the hospital.

Entities:  

Year:  1997        PMID: 11173621     DOI: 10.1007/bf02893349

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  9 in total

1.  Prognostic signs and the role of operative management in acute pancreatitis.

Authors:  J H Ranson; K M Rifkind; D F Roses; S D Fink; K Eng; F C Spencer
Journal:  Surg Gynecol Obstet       Date:  1974-07

2.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

3.  Risk factors in acute pancreatitis.

Authors:  S Bank; L Wise; M Gersten
Journal:  Am J Gastroenterol       Date:  1983-10       Impact factor: 10.864

4.  Characterization of a rat pancreatic secretory protein associated with pancreatitis.

Authors:  V Keim; J L Iovanna; G Rohr; K H Usadel; J C Dagorn
Journal:  Gastroenterology       Date:  1991-03       Impact factor: 22.682

Review 5.  The acute phase reaction of the exocrine pancreas. Gene expression and synthesis of pancreatitis-associated proteins.

Authors:  V Keim; J L Iovanna; J C Dagorn
Journal:  Digestion       Date:  1994       Impact factor: 3.216

6.  C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis.

Authors:  P Puolakkainen; V Valtonen; A Paananen; T Schröder
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

Review 7.  Assessment of severity in acute pancreatitis.

Authors:  N Agarwal; C S Pitchumoni
Journal:  Am J Gastroenterol       Date:  1991-10       Impact factor: 10.864

8.  Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis.

Authors:  D I Heath; A Cruickshank; M Gudgeon; A Jehanli; A Shenkin; C W Imrie
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

9.  Serum levels of pancreatitis-associated protein as indicators of the course of acute pancreatitis. Multicentric Study Group on Acute Pancreatitis.

Authors:  J L Iovanna; V Keim; I Nordback; G Montalto; J Camarena; C Letoublon; P Lévy; P Berthézène; J C Dagorn
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.